Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07345767 · ClinicalTrials.gov registry record · NA
Hypknowledge Nationwide Sleep Extension
A NA study of Short Sleep Duration, sponsored by University of Arizona.
- Recruiting
- Registry status
- NA
- Development phase
- 1,038
- Enrollment target
- 1
- Study location
NCT07345767: Recruiting NA study of Short Sleep Duration, sponsored by University of Arizona.
NCT07345767 is a NA study of Short Sleep Duration that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 1,038 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07345767, a NA study of Short Sleep Duration, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,038 participants
- Enrollment target
- 1
- Study location
Study Summary
The main goal of this study is to evaluate whether a manually determined sleep extension intervention is effective at improving sleep and related outcomes among adults who find it difficult to get enough sleep.
Primary Outcome
Measured in minutes. It is trended from enrollment until the end of the study
Conditions Studied
Interventions
- BEHAVIORAL Sleep Diary
- BEHAVIORAL Fitbit
Study Locations (1)
Arizona
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,038 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
What NCT07345767 shows while recruiting
NCT07345767 is an interventional study that assigns participants to a tested intervention. Its 1,038 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Short Sleep Duration appearing as the primary indexed condition, and to 2 interventions - of which Sleep Diary is the first listed.
NCT07345767 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT07345767 about?
NCT07345767 is a clinical study titled "Hypknowledge Nationwide Sleep Extension". The main goal of this study is to evaluate whether a manually determined sleep extension intervention is effective at improving sleep and related outcomes among adults who find it difficult to get enough sleep.
What is the current status of trial NCT07345767?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,038 participants. The study started on 2026-03-01. Estimated completion is 2027-05-31.
What conditions does trial NCT07345767 study?
This clinical trial studies the following conditions: Short Sleep Duration.
What interventions are being tested in trial NCT07345767?
The interventions under investigation include: Sleep Diary (BEHAVIORAL), Fitbit (BEHAVIORAL).
Who is sponsoring clinical trial NCT07345767?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07345767 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07345767's enrollment target sits among peer trials
1,038 101st of 2000 higher than 1,900 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05219110 · 1,040 participants · NA
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
- NCT06564948 · 1,040 participants · NA
Treatment for Individuals Interacting with the Criminal Justice System
- NCT06661720 · 1,040 participants · Phase 3
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- NCT05037682 · 1,035 participants · NA
Pain and Opioid Management in Older Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI